113 related articles for article (PubMed ID: 37807773)
1. Observational analysis of clinical and pathological characteristics and their prognostic impact in Mexican patients with breast cancer: A multi-center study.
Gozalishvilli-Boncheva A; Gonzalez-Espinoza IR; Castro-Ponce A; Bravo-Gutiérrez OA; Juárez-Salazar G; Montes-de-Oca-Moreda RI; Aguirre-Flores E; Coyotl-Huexotl M; Orozco-Luis J; Chiquillo-Domínguez M; Garibay-Díaz JC; Aranda-Claussen JE; Ponce-de-León EA; Sánchez-Sosa S; Sabaté-Fernández M; García-Reyna JC; Cordero-Vargas C; González-Blanco MJ; Aguilar-Priego JM; Sánchez-Fernández NJ; Cortés-García CA; González-Lozada LE; Miguel-Cruz E; Ceja-Utrera FJ; Hernández-Garcia MS; Piña-Vazquez M; Aguilar-Jiménez C
Breast Dis; 2023; 42(1):305-313. PubMed ID: 37807773
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and pathological features of breast cancer in a population of Mexico].
Maffuz-Aziz A; Labastida-Almendaro S; Espejo-Fonseca A; Rodríguez-Cuevas S
Cir Cir; 2017; 85(3):201-207. PubMed ID: 27658545
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and survival analysis of different subtypes of patients with breast cancer brain metastases.
Bai B; Yuan ZY; Liu DG; Teng XY; Wang SS
Chin J Cancer; 2010 Apr; 29(4):413-9. PubMed ID: 20346218
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
[TBL] [Abstract][Full Text] [Related]
5. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience.
Ustaalioglu BO; Bilici A; Kefeli U; Şeker M; Oncel M; Gezen C; Gumus M; Demirelli F
Am J Clin Oncol; 2012 Dec; 35(6):580-6. PubMed ID: 21926901
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and survival analysis of breast cancer molecular subtypes with hepatic metastases.
Ge QD; Lv N; Kong YN; Xie XH; He N; Xie XM; Wei WD
Asian Pac J Cancer Prev; 2012; 13(10):5081-6. PubMed ID: 23244114
[TBL] [Abstract][Full Text] [Related]
7. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the primary tumor location on the prognosis of breast invasive ductal carcinoma patients treated with radical mastectomy].
Wang YT; Chen ZJ; Zhang D; Zhou H; Cao XC; Wang X
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):686-692. PubMed ID: 31550859
[No Abstract] [Full Text] [Related]
9. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
11. Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes.
Kim J; Lee S; Bae S; Choi MY; Lee J; Jung SP; Kim S; Choe JH; Kim JH; Kim JS; Lee JE; Nam SJ; Yang JH
Breast Cancer Res Treat; 2012 Jan; 131(2):527-40. PubMed ID: 22042364
[TBL] [Abstract][Full Text] [Related]
12. Primary prognostic factors in invasive breast cancer with special reference to ductal carcinoma and histologic malignancy grade.
Garne JP; Aspegren K; Linell F; Rank F; Ranstam J
Cancer; 1994 Mar; 73(5):1438-48. PubMed ID: 8111711
[TBL] [Abstract][Full Text] [Related]
13. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
[TBL] [Abstract][Full Text] [Related]
15. Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients.
Flores-Díaz D; Arce C; Flores-Luna L; Reynoso-Noveron N; Lara-Medina F; Matus JA; Bargallo-Rocha E; Pérez V; Villarreal-Garza C; Cabrera-Galeana P; Mohar A
Breast Cancer Res Treat; 2019 Jul; 176(1):243-249. PubMed ID: 30997623
[TBL] [Abstract][Full Text] [Related]
16. Reconsideration of clinical and histopathological prognostic factors in breast cancer patients: a single center experience.
Tanriverdi O; Meydan N; Barutca S
Asian Pac J Cancer Prev; 2014; 15(2):807-12. PubMed ID: 24568500
[TBL] [Abstract][Full Text] [Related]
17. Aneuploidy identifies subsets of patients with poor clinical outcome in grade 1 and grade 2 breast cancer.
Pinto AE; Pereira T; Silva GL; André S
Breast; 2015 Aug; 24(4):449-55. PubMed ID: 25920680
[TBL] [Abstract][Full Text] [Related]
18. HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy.
Jia H; Jia W; Yang Y; Li S; Feng H; Liu J; Rao N; Jin L; Wu J; Gu R; Zhu L; Chen K; Deng H; Zeng Y; Liu Q; Song E; Su F
World J Surg Oncol; 2014 Sep; 12():289. PubMed ID: 25241216
[TBL] [Abstract][Full Text] [Related]
19. Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancers.
Corona SP; Bortul M; Scomersi S; Bigal C; Bottin C; Zanconati F; Fox SB; Giudici F; Generali D
Breast Cancer Res Treat; 2020 Apr; 180(3):735-745. PubMed ID: 32060782
[TBL] [Abstract][Full Text] [Related]
20. Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.
Serrero G; Hawkins DM; Yue B; Ioffe O; Bejarano P; Phillips JT; Head JF; Elliott RL; Tkaczuk KR; Godwin AK; Weaver J; Kim WE
Breast Cancer Res; 2012 Feb; 14(1):R26. PubMed ID: 22316048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
